Moreover, we tried to determine whether the mutants of GIT1 (GIT1Mut1: GIT1L271A; GIT1Mut2: GIT1L279A) influenced the drug-induced inhibition of gastric cancer cell invasion and Rac1 activation. Here, GIT1 is linked to gastric cancer.